Do analysts recommend RANG or BBOT?

BridgeBio Oncology Therapeutics has a consensus price target of $25.00, suggesting a potential upside of 222.79%. Given BridgeBio Oncology Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe BridgeBio Oncology Therapeutics is more favorable than Range Capital Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Range Capital Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BridgeBio Oncology Therapeutics 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60

Which has preferable earnings and valuation, RANG or BBOT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Range Capital Acquisition N/A N/A N/A N/A N/A BridgeBio Oncology Therapeutics N/A N/A -$134.04M -$2.05 N/A

Is RANG or BBOT more profitable?

Company Net Margins Return on Equity Return on Assets Range Capital Acquisition N/A N/A N/A BridgeBio Oncology Therapeutics N/A N/A N/A

Which has higher earnings & valuation, RANG or ILPT?

Range Capital Acquisition has higher earnings, but lower revenue than Industrial Logistics Properties Trust. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Range Capital Acquisition N/A N/A N/A N/A N/A Industrial Logistics Properties Trust $448.85M 1.31 -$66.19M -$0.82 N/A

Do analysts rate AEXA or RANG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Exceptionalism Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Range Capital Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, AEXA or RANG?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Exceptionalism Acquisition N/A N/A -$7.20M $0.06 188.90 Range Capital Acquisition N/A N/A N/A N/A N/A

Is AEXA or RANG more profitable?

Company Net Margins Return on Equity Return on Assets American Exceptionalism Acquisition N/A N/A N/A Range Capital Acquisition N/A N/A N/A

Which has higher earnings and valuation, GEMI or RANG?

Range Capital Acquisition has lower revenue, but higher earnings than Gemini Space Station. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gemini Space Station $179.57M 3.24 -$582.81M -$3.96 N/A Range Capital Acquisition N/A N/A N/A N/A N/A

Is GEMI or RANG more profitable?

Company Net Margins Return on Equity Return on Assets Gemini Space Station N/A N/A N/A Range Capital Acquisition N/A N/A N/A

Do analysts recommend CSHR or RANG?

CoinShares presently has a consensus target price of $9.00, indicating a potential upside of 107.85%. Given CoinShares' stronger consensus rating and higher possible upside, analysts plainly believe CoinShares is more favorable than Range Capital Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CoinShares 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Range Capital Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, CSHR or RANG?

CoinShares has higher revenue and earnings than Range Capital Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CoinShares $165.68M 3.44 $5.54M $0.18 24.06 Range Capital Acquisition N/A N/A N/A N/A N/A

Is CSHR or RANG more profitable?

Range Capital Acquisition's return on equity of 0.00% beat CoinShares' return on equity. Company Net Margins Return on Equity Return on Assets CoinShares N/A -100.73% 2.40% Range Capital Acquisition N/A N/A N/A

Range Capital Acquisition (RANG) Competitors

$10.61 0.00 (-0.04%)

As of 01:18 PM Eastern

Compare

RANG vs. BBOT, ILPT, AEXA, GEMI, and CSHR

Should you buy Range Capital Acquisition stock or one of its competitors? MarketBeat compares Range Capital Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Range Capital Acquisition include BridgeBio Oncology Therapeutics (BBOT), Industrial Logistics Properties Trust (ILPT), American Exceptionalism Acquisition (AEXA), Gemini Space Station (GEMI), and CoinShares (CSHR). These companies are all part of the "trading" industry.

How does Range Capital Acquisition compare to BridgeBio Oncology Therapeutics?

Range Capital Acquisition (NASDAQ:RANG) and BridgeBio Oncology Therapeutics (NASDAQ:BBOT) are both small-cap financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

54.9% of BridgeBio Oncology Therapeutics shares are owned by institutional investors. 25.6% of Range Capital Acquisition shares are owned by insiders. Comparatively, 24.4% of BridgeBio Oncology Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, BridgeBio Oncology Therapeutics had 10 more articles in the media than Range Capital Acquisition. MarketBeat recorded 11 mentions for BridgeBio Oncology Therapeutics and 1 mentions for Range Capital Acquisition. Range Capital Acquisition's average media sentiment score of 1.87 beat BridgeBio Oncology Therapeutics' score of 0.04 indicating that Range Capital Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Range Capital Acquisition	Very Positive
BridgeBio Oncology Therapeutics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Range Capital Acquisition	N/A	N/A	N/A	N/A	N/A
BridgeBio Oncology Therapeutics	N/A	N/A	-$134.04M	-$2.05	N/A

Company	Net Margins	Return on Equity	Return on Assets
Range Capital Acquisition	N/A	N/A	N/A
BridgeBio Oncology Therapeutics	N/A	N/A	N/A

Range Capital Acquisition has a beta of 0.08, indicating that its share price is 92% less volatile than the broader market. Comparatively, BridgeBio Oncology Therapeutics has a beta of 0.29, indicating that its share price is 71% less volatile than the broader market.

BridgeBio Oncology Therapeutics has a consensus price target of $25.00, suggesting a potential upside of 222.79%. Given BridgeBio Oncology Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe BridgeBio Oncology Therapeutics is more favorable than Range Capital Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Range Capital Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BridgeBio Oncology Therapeutics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

BridgeBio Oncology Therapeutics beats Range Capital Acquisition on 6 of the 8 factors compared between the two stocks.

How does Range Capital Acquisition compare to Industrial Logistics Properties Trust?

Range Capital Acquisition (NASDAQ:RANG) and Industrial Logistics Properties Trust (NASDAQ:ILPT) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Range Capital Acquisition has a net margin of 0.00% compared to Industrial Logistics Properties Trust's net margin of -11.93%. Range Capital Acquisition's return on equity of 0.00% beat Industrial Logistics Properties Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Range Capital Acquisition	N/A	N/A	N/A
Industrial Logistics Properties Trust	-11.93%	-5.93%	-1.04%

Industrial Logistics Properties Trust has a consensus price target of $7.40, suggesting a potential downside of 16.29%. Given Industrial Logistics Properties Trust's stronger consensus rating and higher possible upside, analysts clearly believe Industrial Logistics Properties Trust is more favorable than Range Capital Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Range Capital Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Industrial Logistics Properties Trust	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

49.1% of Industrial Logistics Properties Trust shares are held by institutional investors. 25.6% of Range Capital Acquisition shares are held by insiders. Comparatively, 2.3% of Industrial Logistics Properties Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Industrial Logistics Properties Trust had 3 more articles in the media than Range Capital Acquisition. MarketBeat recorded 4 mentions for Industrial Logistics Properties Trust and 1 mentions for Range Capital Acquisition. Range Capital Acquisition's average media sentiment score of 1.87 beat Industrial Logistics Properties Trust's score of 1.20 indicating that Range Capital Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Range Capital Acquisition	Very Positive
Industrial Logistics Properties Trust	Positive

Range Capital Acquisition has higher earnings, but lower revenue than Industrial Logistics Properties Trust.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Range Capital Acquisition	N/A	N/A	N/A	N/A	N/A
Industrial Logistics Properties Trust	$448.85M	1.31	-$66.19M	-$0.82	N/A

Range Capital Acquisition has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market. Comparatively, Industrial Logistics Properties Trust has a beta of 2.5, meaning that its share price is 150% more volatile than the broader market.

Summary

Industrial Logistics Properties Trust beats Range Capital Acquisition on 7 of the 12 factors compared between the two stocks.

How does Range Capital Acquisition compare to American Exceptionalism Acquisition?

American Exceptionalism Acquisition (NYSE:AEXA) and Range Capital Acquisition (NASDAQ:RANG) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

In the previous week, Range Capital Acquisition had 1 more articles in the media than American Exceptionalism Acquisition. MarketBeat recorded 1 mentions for Range Capital Acquisition and 0 mentions for American Exceptionalism Acquisition. Range Capital Acquisition's average media sentiment score of 1.87 beat American Exceptionalism Acquisition's score of 0.00 indicating that Range Capital Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
American Exceptionalism Acquisition	Neutral
Range Capital Acquisition	Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Exceptionalism Acquisition	N/A	N/A	-$7.20M	$0.06	188.90
Range Capital Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Exceptionalism Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Range Capital Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
American Exceptionalism Acquisition	N/A	N/A	N/A
Range Capital Acquisition	N/A	N/A	N/A

Summary

Range Capital Acquisition beats American Exceptionalism Acquisition on 2 of the 2 factors compared between the two stocks.

How does Range Capital Acquisition compare to Gemini Space Station?

Gemini Space Station (NASDAQ:GEMI) and Range Capital Acquisition (NASDAQ:RANG) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Gemini Space Station currently has a consensus target price of $12.52, indicating a potential upside of 156.98%. Given Gemini Space Station's stronger consensus rating and higher probable upside, equities research analysts plainly believe Gemini Space Station is more favorable than Range Capital Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gemini Space Station	2 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.08
Range Capital Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Gemini Space Station	N/A	N/A	N/A
Range Capital Acquisition	N/A	N/A	N/A

Range Capital Acquisition has lower revenue, but higher earnings than Gemini Space Station.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gemini Space Station	$179.57M	3.24	-$582.81M	-$3.96	N/A
Range Capital Acquisition	N/A	N/A	N/A	N/A	N/A

In the previous week, Gemini Space Station had 2 more articles in the media than Range Capital Acquisition. MarketBeat recorded 3 mentions for Gemini Space Station and 1 mentions for Range Capital Acquisition. Range Capital Acquisition's average media sentiment score of 1.87 beat Gemini Space Station's score of 0.62 indicating that Range Capital Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Gemini Space Station	Positive
Range Capital Acquisition	Very Positive

Summary

Gemini Space Station beats Range Capital Acquisition on 5 of the 6 factors compared between the two stocks.

How does Range Capital Acquisition compare to CoinShares?

CoinShares (NASDAQ:CSHR) and Range Capital Acquisition (NASDAQ:RANG) are both small-cap financial services companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, media sentiment, profitability, valuation and institutional ownership.

CoinShares has higher revenue and earnings than Range Capital Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CoinShares	$165.68M	3.44	$5.54M	$0.18	24.06
Range Capital Acquisition	N/A	N/A	N/A	N/A	N/A

In the previous week, CoinShares had 2 more articles in the media than Range Capital Acquisition. MarketBeat recorded 3 mentions for CoinShares and 1 mentions for Range Capital Acquisition. Range Capital Acquisition's average media sentiment score of 1.87 beat CoinShares' score of 0.84 indicating that Range Capital Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
CoinShares	Positive
Range Capital Acquisition	Very Positive

CoinShares has a beta of -1.68, indicating that its stock price is 268% less volatile than the broader market. Comparatively, Range Capital Acquisition has a beta of 0.08, indicating that its stock price is 92% less volatile than the broader market.

CoinShares presently has a consensus target price of $9.00, indicating a potential upside of 107.85%. Given CoinShares' stronger consensus rating and higher possible upside, analysts plainly believe CoinShares is more favorable than Range Capital Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CoinShares	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Range Capital Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Range Capital Acquisition's return on equity of 0.00% beat CoinShares' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CoinShares	N/A	-100.73%	2.40%
Range Capital Acquisition	N/A	N/A	N/A

Summary

CoinShares beats Range Capital Acquisition on 6 of the 9 factors compared between the two stocks.

Get Range Capital Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RANG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RANG vs. The Competition

Export

Metric	Range Capital Acquisition	Investment Offices Industry	Financial Sector	NASDAQ Exchange
Market Cap	$148.50M	$320.00M	$5.98B	$12.24B
Dividend Yield	N/A	N/A	5.27%	5.66%
P/E Ratio	N/A	2.26	16.38	24.49
Price / Sales	N/A	188.26	1,287.43	138.52
Price / Cash	N/A	135.83	48.67	37.92
Price / Book	N/A	348.74	6.59	6.76
Net Income	N/A	-$66.73M	$1.13B	$337.21M
7 Day Performance	-0.13%	-0.39%	1.54%	2.07%
1 Month Performance	0.10%	2.11%	2.05%	3.95%
1 Year Performance	3.47%	2.22%	20.59%	29.04%

Range Capital Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RANG Range Capital Acquisition	1.1401 of 5 stars	$10.61 0.0%	N/A	+1.6%	$148.50M	N/A	N/A	N/A	Positive News
BBOT BridgeBio Oncology Therapeutics	2.2352 of 5 stars	$7.37 -5.3%	$25.00 +239.4%	N/A	$592.17M	N/A	N/A	N/A
ILPT Industrial Logistics Properties Trust	2.8538 of 5 stars	$8.77 +2.9%	$7.40 -15.6%	+161.3%	$585.36M	$448.85M	N/A	600	Positive News
AEXA American Exceptionalism Acquisition	N/A	$11.24 -0.5%	N/A	N/A	$557.91M	N/A	188.00	2
GEMI Gemini Space Station	2.7547 of 5 stars	$4.51 -6.3%	$12.52 +177.9%	N/A	$539.07M	$179.57M	N/A	700	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RANG) was last updated on 6/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Range Capital Acquisition (RANG) Competitors

RANG vs. BBOT, ILPT, AEXA, GEMI, and CSHR

How does Range Capital Acquisition compare to BridgeBio Oncology Therapeutics?

Summary

How does Range Capital Acquisition compare to Industrial Logistics Properties Trust?

Summary

How does Range Capital Acquisition compare to American Exceptionalism Acquisition?

Summary

How does Range Capital Acquisition compare to Gemini Space Station?

Summary

How does Range Capital Acquisition compare to CoinShares?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RANG vs. The Competition

Range Capital Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Range Capital Acquisition (RANG) Competitors

RANG vs. BBOT, ILPT, AEXA, GEMI, and CSHR

How does Range Capital Acquisition compare to BridgeBio Oncology Therapeutics?

Do insiders and institutionals have more ownership in RANG or BBOT?

Does the media favor RANG or BBOT?

Which has preferable earnings and valuation, RANG or BBOT?

Is RANG or BBOT more profitable?

Which has more volatility and risk, RANG or BBOT?

Do analysts recommend RANG or BBOT?

Summary

How does Range Capital Acquisition compare to Industrial Logistics Properties Trust?

Is RANG or ILPT more profitable?

Do analysts rate RANG or ILPT?

Do insiders & institutionals believe in RANG or ILPT?

Does the media refer more to RANG or ILPT?

Which has higher earnings & valuation, RANG or ILPT?

Which has more risk and volatility, RANG or ILPT?

Summary

How does Range Capital Acquisition compare to American Exceptionalism Acquisition?

Does the media prefer AEXA or RANG?

Which has higher valuation and earnings, AEXA or RANG?

Do analysts rate AEXA or RANG?

Is AEXA or RANG more profitable?

Summary

How does Range Capital Acquisition compare to Gemini Space Station?

Do analysts prefer GEMI or RANG?

Is GEMI or RANG more profitable?

Which has higher earnings and valuation, GEMI or RANG?

Does the media favor GEMI or RANG?

Summary

How does Range Capital Acquisition compare to CoinShares?

Which has higher valuation and earnings, CSHR or RANG?

Does the media favor CSHR or RANG?

Which has more volatility & risk, CSHR or RANG?

Do analysts recommend CSHR or RANG?

Is CSHR or RANG more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RANG vs. The Competition

Range Capital Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools